… of future SARS-CoV-2 booster doses. In this study, we examined neutralizing antibody (nAb)
titers in 48 vaccinated health care workers (HCWs) against the major SARS-CoV-2 …

… symptomatic infection with a similar virus. Here we extend that work to show that neutralising
antibodies are also highly predictive of protection from SARS-CoV-2 variants of concern. …

… Hence, the neutralizing potency of the … of neutralizing the emerging variants. In this
section we discuss several of these antibodies and describe their interaction with the SARS-CoV-2 …

… In this study, we demonstrated the potential therapeutic benefit of neutralizing antibody
CT-P59 targeting RBD of SARS-CoV-2 in vitro and in vivo studies. We found that CT-P59 binds to …

… the antibody response to SARS-CoV-2 and SARS-CoV infection. … of antibody responses to
SARS-CoV-2 and SARS-CoV in … -neutralizing response to both SARSCoV-2 and SARS-CoV …

… coronavirus 2 (SARS-CoV-2) exhibits reduced susceptibility to vaccine-induced neutralizing
antibodies, … We assess the magnitude and short-term durability of neutralizing antibodies …

… As for the ramifications of our findings for the protective efficacy of current SARS-CoV-2
vaccines, the neutralizing activity of sera from vaccinated individuals against B.1.1.7 is largely …

… Our pseudotyped virus neutralization assay has been validated in this study with … SARS-CoV-2
virus neutralization and previously (36). However, while pseudotyped virus neutralization …

… the neutralizing abilities of most of the other antibodies. We also find that 515-5 could cross
neutralize the SARS-CoV … neutralizing antibodies for COVID-19 as therapeutic candidates. …

… These data suggest that neutralizing antibodies can protect against SARS-CoV-2-induced
lung inflammation. In summary, we have developed a model of SARS-CoV-2 lung infection …